PIPERACILLIN SODIUM Recall D-0627-2023
Description: Piperacillin and Tazobactam for Injection, USP, 3.375 grams per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017, NDC 66794-217-41
PIPERACILLIN SODIUM Recall D-0627-2023 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0627-2023 |
Event ID | 92341 |
Brand | PIPERACILLIN AND TAZOBACTAM |
Generic Name | PIPERACILLIN AND TAZOBACTAM |
Manufacturer | PIPERACILLIN AND TAZOBACTAM |
Original Package? | 1 |
Active Substance | PIPERACILLIN SODIUM TAZOBACTAM SODIUM |
Drug Route | INTRAVENOUS |
Distribution | Nationwide within the United States |
Quantity | 223,590 vials |
Recall Reason | Lack of Assurance of Sterility |
Drug Classification | Class II |
Drug Code Info | 20230524 |
Product NDC | 66794-216 66794-217 66794-218 |
Recall Initiation Date | 20230515 |
Report Date | 20230524 |
Classification Date | 20230518 |
Address | 911 G I D C Makarpura Vadodara, India |
Recalling Firm | Astral SteriTech Private Ltd. |
Initial Notification | Letter |
Unique Ingredient Identifier | M98T69Q7HP UXA545ABTT |
Drug Application Number | ANDA212287 |
Structured Product Labeling (SPL ID) | f0ce0e63-c11e-3ce6-e053-2995a90a50f5 |
Structured Product Labeling (SPL Set ID) | 876b22e3-de45-5ddc-e053-2a95a90ac886 |
Similar To |